Literature DB >> 6615697

Trends in mortality from carcinoma of the liver and the use of oral contraceptives.

D Forman, R Doll, R Peto.   

Abstract

There is increasing concern that contraceptive pill usage may increase the risk of hepatocellular carcinoma. As primary malignant liver cancer is very rare in this country, any effect due to oral contraceptives should be apparent in national mortality statistics. An analysis of mortality rates over the last 24 years shows a small but consistent increase for young women starting to occur during the end of the last decade. However no such trend is apparent in data from other countries where pill usage is comparable to that in the U.K. Overall liver cancer remains an extremely uncommon cause of death in developed countries, but it will be particularly important to monitor trends in this disease in the future.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615697      PMCID: PMC2011472          DOI: 10.1038/bjc.1983.199

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

Review 1.  Hepatic tumors: possible relationship to use of oral contraceptives.

Authors:  G Klatskin
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

2.  Possible association between benign hepatomas and oral contraceptives.

Authors:  J K Baum; J J Bookstein; F Holtz; E W Klein
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

Review 3.  Some aspects of the interaction between natural and synthetic female sex hormones and the liver.

Authors:  H Adlercreutz; R Tenhunen
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

4.  Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.

Authors:  J D Yager; R Yager
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

5.  Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis.

Authors:  J Neuberger; B Portmann; H B Nunnerley; J W Laws; M Davis; R Williams
Journal:  Lancet       Date:  1980-02-09       Impact factor: 79.321

6.  Hepatocellular carcinoma in young women on oral contraceptives.

Authors:  W M Christopherson; E T Mays; G Barrows
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

7.  Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.

Authors:  M Davis; B Portmann; M Searle; R Wright; R Williams
Journal:  Br Med J       Date:  1975-11-29

8.  Liver-cell adenomas associated with use of oral contraceptives.

Authors:  H A Edmondson; B Henderson; B Benton
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

9.  Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.

Authors:  J B Rooks; H W Ory; K G Ishak; L T Strauss; J R Greenspan; A P Hill; C W Tyler
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

10.  Primary liver tumors and oral contraceptives. Results of a survey.

Authors:  J Vana; G P Murphy; B L Aronoff; H W Baker
Journal:  JAMA       Date:  1977-11-14       Impact factor: 56.272

View more
  10 in total

1.  Oral contraceptives and hepatocellular carcinoma.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

2.  Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats.

Authors:  L Klotz; H J Hacker; D Klingmüller; P Bannasch; U Pfeifer; F Dombrowski
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Cancer of the liver and the use of oral contraceptives.

Authors:  D Forman; T J Vincent; R Doll
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

4.  The epidemiology of primary liver cancer in a West German population: the Saarland.

Authors:  K Rimkus; G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Oral contraceptives and hepatocellular carcinoma.

Authors:  J Neuberger; D Forman; R Doll; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

Review 6.  Hepatobiliary complications of oral contraceptives.

Authors:  M C Lindberg
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

7.  [Ethinyl estradiol and hepatocarcinogenesis. An experimental study].

Authors:  K de Heer; G Klöppel; H W Schreiber
Journal:  Langenbecks Arch Chir       Date:  1987

8.  Oral contraceptives and primary liver cancer.

Authors:  C La Vecchia; E Negri; F Parazzini
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

9.  Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei.

Authors:  S J Van Rensburg; P Cook-Mozaffari; D J Van Schalkwyk; J J Van der Watt; T J Vincent; I F Purchase
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

10.  Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.

Authors:  J W Mant; M P Vessey
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.